ReCode Therapeutics, Inc. — Menlo Park, California

ReCode Therapeutics, Inc. is a clinical research site located in Menlo Park, California, United States 94025.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

ReCode Therapeutics, Inc. has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Primary Ciliary Dyskinesia.

Sponsors: ReCode Therapeutics.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ReCode Therapeutics, Inc.?

ReCode Therapeutics, Inc. has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ReCode Therapeutics, Inc. conducted?

ReCode Therapeutics, Inc. has 1 clinical trials on record, with 1 currently active. Their work covers Primary Ciliary Dyskinesia.

Is ReCode Therapeutics, Inc. accredited by Crixeo Health?

ReCode Therapeutics, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about ReCode Therapeutics, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.